Loading…
Dabrafenib plus trametinib in patients with BRAF V600–mutant melanoma brain metastases (COMBI-MB): a multi-cohort, open-label, phase 2 trial
Saved in:
Published in: | The lancet oncology 2017-06, Vol.18 (7), p.863-873 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 1470-2045 1474-5488 |
DOI: | 10.1016/S1470-2045(17)30429-1 |